Antibody-drug conjugates, or ADCs, have emerged as a significant class of cancer therapies over the past two decades. New...
“There’s a clear connection between cancer and the gut microbiome,” began Matthew Redinbo, PhD, at the opening keynote address...
Guest post by Bianca N. Islam, MD, PhD At 1 a.m., I get a page from the nursing staff...
By Carmine S. Leggett, PhD Clinical trials in oncology have changed the face of cancer treatment, allowing cancer researchers...
Circulating tumor DNA (ctDNA) was first detected over 30 years ago, but its potential uses for cancer diagnosis and...
February is National Cancer Prevention Month. We recently had the opportunity to speak with American Association for Cancer Research...
There’s a quiet corner of the San Diego Convention Center where snacks and toys are plentiful, and naps are...
Today is International Day of Women and Girls in Science, a United Nations initiative aimed at encouraging full and...
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
Despite considerable progress against cancer, the disease continues to take a huge toll on global health. Each year, approximately...
While there have been great strides in lowering the incidence and mortality rates of cervical cancer in the United...